AGP Picks
View all

DC STEM Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.

Press releases published on April 27, 2026

One Stop Systems to Report First Quarter 2026 Financial Results
Microchip Increases Manufacturing Capacity of its Hydrogen Masers
Kaltura Unveils Avatar-Powered Roleplay Solution for Enterprise Training and Simulations
Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty
Cerence to Announce Fiscal Second Quarter Results on May 7, 2026
Piano Software Names Nick Worth CEO
Feedonomics Unlocks Agentic Discovery with Agentic Catalog Exports
Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026
Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury
Magnite Unveils New AI-Powered Intelligent Assistance and Agentic Execution Capabilities, Empowering Media Owners and Buyers
Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01
Identity Digital Launches Neutral, DNS-Anchored Identity Standard for AI Agents
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% to Expand Indication for Treatment of Atopic Dermatitis to Infants Down to 3 Months
Global-e to Announce Financial Results for the First Quarter 2026 on May 13, 2026
Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit
Alpha Compute AI GPU Launch Update; First Large-Scale NVIDIA Blackwell Cluster
Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation
Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

DC STEM Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.